Ultralife Corp (ULBI, Financial) is set to release its Q3 2024 earnings on Nov 8, 2024. The consensus estimate for Q3 2024 revenue is $43 million, and the earnings are expected to come in at $0.18 per share. The full year 2024's revenue is expected to be $172 million and the earnings are expected to be $0.69 per share. More detailed estimate data can be found on the Forecast page.
Ultralife Corp (ULBI, Financial) Estimate Trends
Over the past 90 days, revenue estimates for Ultralife Corp (ULBI) have remained stable at $172 million for the full year 2024 and $187 million for 2025. Similarly, earnings estimates have remained constant at $0.69 per share for the full year 2024 and $0.83 per share for 2025.
Ultralife Corp (ULBI, Financial) Reported History
In the previous quarter of 2024-06-30, Ultralife Corp's (ULBI) actual revenue was $42.98 million, which beat analysts' revenue expectations of $42 million by 2.34%. Ultralife Corp's (ULBI) actual earnings were $0.18 per share, which beat analysts' earnings expectations of $0.12 per share by 50%. After releasing the results, Ultralife Corp (ULBI) was down by -4.05% in one day.
Ultralife Corp (ULBI, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 1 analyst, the average target price for Ultralife Corp (ULBI) is $14 with a high estimate of $14 and a low estimate of $14. The average target implies an upside of 48.31% from the current price of $9.44.
Based on GuruFocus estimates, the estimated GF Value for Ultralife Corp (ULBI, Financial) in one year is $8.86, suggesting a downside of -6.14% from the current price of $9.44.
Based on the consensus recommendation from 1 brokerage firm, Ultralife Corp's (ULBI, Financial) average brokerage recommendation is currently 2.0, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.